Hair loss is a common adverse effect of antiepileptic drugs, especially in association with valproic acid and carbamazepine. The development of hair loss with newer antiepileptic drug therapy is relatively rare. We present a 15-year-old girl with frontal lobe epilepsy who developed hair loss after two months of topiramate adjunctive therapy. The hair loss was reversible upon discontinuation of topiramate, but recurred after reintroduction of the drug. Hair loss should be considered an adverse effect in topiramate adjunctive therapy. It may have significant cosmetic impact and psychosocial relevance, especially in children and young adults.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.